Gene trawl shows curing cancer harder than thought
September 4, 2008 — WASHINGTON (Reuters) - Cancer experts who probed every gene in tumors from two of the hardest-to-treat cancers found that cancer is much more complicated than anyone thought -- and say they found why a cure is so unlikely after a tumor has spread.
Approach enlists immune system to fight leukemia
June 20, 2008 — CHICAGO (Reuters) - Leukemia patients may be able to avoid developing resistance to the drug Gleevec through a mathematical formula that predicts when they should receive an immune-boosting vaccine, researchers said on Thursday.
Cancer drug may harm the developing fetus
March 7, 2008 — NEW YORK (Reuters Health) - The majority of women who become pregnant while taking the cancer drug Gleevec, usually for a type of blood cancer called chronic myeloid leukemia, will probably have a successful outcome. However, there is a substantial risk of serious fetal malformations, according to a study reported this week.
Select news items provided by Reuters Health